Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin B Leon

Showing results (291-300 of 928) with videos related to

Pageof 93
Sort By:
European Heart Journal|July 17, 2018
Development of significant tricuspid regurgitation over time and prognostic implications: new insights into natural historyEdgard A Prihadi, Pieter van der Bijl, Erhan Gursoy, et al.
JAMA Cardiology|May 6, 2026
Sex-Based Patterns and Trends in Transcatheter Aortic Valve ImplantationJohny Nicolas, Annetine C Gelijns, Alan J Moskowitz, et al.
Lancet (London, England)|September 21, 2022
Long-term outcomes after catheter-based renal artery denervation for resistant hypertension: final follow-up of the randomised SYMPLICITY HTN-3 TrialDeepak L Bhatt, Muthiah Vaduganathan, David E Kandzari, et al.
JACC. Cardiovascular Interventions|August 23, 2023
Stressed Blood Volume in Severe Tricuspid Regurgitation: Implications for Transcatheter TreatmentKarl-Philipp Rommel, Christian Besler, Matthias Unterhuber, et al.
Journal of Cardiovascular Computed Tomography|August 1, 2016
Practical considerations for optimizing cardiac computed tomography protocols for comprehensive acquisition prior to transcatheter aortic valve replacementOmar K Khalique, Todd C Pulerwitz, Sandra S Halliburton, et al.
Circulation|February 11, 2004
Analysis of 1-year clinical outcomes in the SIRIUS trial: a randomized trial of a sirolimus-eluting stent versus a standard stent in patients at high risk for coronary restenosisDavid R Holmes, Martin B Leon, Jeffrey W Moses, et al.
Circulation|May 5, 2004
Impact of sirolimus-eluting stents on outcome in diabetic patients: a SIRIUS (SIRolImUS-coated Bx Velocity balloon-expandable stent in the treatment of patients with de novo coronary artery lesions) substudyIssam Moussa, Martin B Leon, Donald S Baim, et al.
Kidney International|January 28, 2005
Low hematocrit predicts contrast-induced nephropathy after percutaneous coronary interventionsEugenia Nikolsky, Roxana Mehran, Zoran Lasic, et al.
The American Journal of Cardiology|July 28, 2004
Impact of chronic kidney disease on prognosis of patients with diabetes mellitus treated with percutaneous coronary interventionEugenia Nikolsky, Roxana Mehran, Diane Turcot, et al.
The American Journal of Cardiology|October 30, 2003
Comparison of effect of glycoprotein IIb/IIIa inhibitors during percutaneous coronary interventions on risk of hemorrhagic stroke in patients >or=75 years of age versus those <75 years of ageIoannis Iakovou, George Dangas, Roxana Mehran, et al.
Pageof 93

Showing results (291-300 of 928) with videos related to

Sort By:
Pageof 93
European Heart Journal|July 17, 2018
Development of significant tricuspid regurgitation over time and prognostic implications: new insights into natural historyEdgard A Prihadi, Pieter van der Bijl, Erhan Gursoy, et al.
JAMA Cardiology|May 6, 2026
Sex-Based Patterns and Trends in Transcatheter Aortic Valve ImplantationJohny Nicolas, Annetine C Gelijns, Alan J Moskowitz, et al.
Lancet (London, England)|September 21, 2022
Long-term outcomes after catheter-based renal artery denervation for resistant hypertension: final follow-up of the randomised SYMPLICITY HTN-3 TrialDeepak L Bhatt, Muthiah Vaduganathan, David E Kandzari, et al.
JACC. Cardiovascular Interventions|August 23, 2023
Stressed Blood Volume in Severe Tricuspid Regurgitation: Implications for Transcatheter TreatmentKarl-Philipp Rommel, Christian Besler, Matthias Unterhuber, et al.
Journal of Cardiovascular Computed Tomography|August 1, 2016
Practical considerations for optimizing cardiac computed tomography protocols for comprehensive acquisition prior to transcatheter aortic valve replacementOmar K Khalique, Todd C Pulerwitz, Sandra S Halliburton, et al.
Circulation|February 11, 2004
Analysis of 1-year clinical outcomes in the SIRIUS trial: a randomized trial of a sirolimus-eluting stent versus a standard stent in patients at high risk for coronary restenosisDavid R Holmes, Martin B Leon, Jeffrey W Moses, et al.
Circulation|May 5, 2004
Impact of sirolimus-eluting stents on outcome in diabetic patients: a SIRIUS (SIRolImUS-coated Bx Velocity balloon-expandable stent in the treatment of patients with de novo coronary artery lesions) substudyIssam Moussa, Martin B Leon, Donald S Baim, et al.
Kidney International|January 28, 2005
Low hematocrit predicts contrast-induced nephropathy after percutaneous coronary interventionsEugenia Nikolsky, Roxana Mehran, Zoran Lasic, et al.
The American Journal of Cardiology|July 28, 2004
Impact of chronic kidney disease on prognosis of patients with diabetes mellitus treated with percutaneous coronary interventionEugenia Nikolsky, Roxana Mehran, Diane Turcot, et al.
The American Journal of Cardiology|October 30, 2003
Comparison of effect of glycoprotein IIb/IIIa inhibitors during percutaneous coronary interventions on risk of hemorrhagic stroke in patients >or=75 years of age versus those <75 years of ageIoannis Iakovou, George Dangas, Roxana Mehran, et al.
Pageof 93